News

A study led by Robert Gerszten, MD, director of clinical and translational research at the Massachusetts General Hospital Institute for Heart, Vascular and Stroke Care, identifies a biomarker that can predict diabetes risk.

Newly discovered biomarker can predict diabetes onset

09/Oct/2013

About 15 percent of the population in the United States has diabetes, which is considered a major risk factor for heart disease. Robert Gerszten, MD, director of clinical and translational research at the Massachusetts General Hospital Institute for Heart, Vascular and Stroke Care, discusses his new study that identifies a biomarker that can predict diabetes risk up to 10 years before the onset of the disease. Dr. Gerszten explains that by using this new technique in the future, physicians may be able to identify patients who have the disease, allowing them to live healthier lives. Watch Dr. Gerszten discuss the study and what it means for patients

patient

U.S. News and World Report Best Hospitals 2014-2015

U.S. News & World Report ranks Mass General #1 in New England and #2 in the nation based on our quality of care, patient safety and reputation in 16 clinical specialties.

Search the Mass General news archive

Search the archive for previously published news articles, press releases and publications.

View all departments

Departments and Centers at Mass General have a reputation for excellence in patient care. View a list of all departments.